PDCD1 and cancer: Most recently, the newly developed cancer fecal microbiota therapy in the clinical trial revealed that fecal microbiota transplant effectively promoted intra-tumoral immune activity and overcame resistance to anti-programmed cell death-1 immunotherapy [222].